Alivus Life Q1 FY27 Results (NSE: ALIVUS)

· Analysis by Alpha Inflection

Signal: Margin expansion

The read

Q1FY27 was a margin inflection quarter: gross margin expanded 521bps YoY on raw material cost relief and mix, while employee cost leverage added to the operating margin swing (EBITDA +249bps YoY). The PAT beat (+31.7% YoY) was amplified by other income tripling, but core operating profit still grew a healthy 30.2%. Sequential revenue decline (-7.1% QoQ) is typical seasonal softness. The key concern is whether 60%+ gross margins are sustainable given sequential compression from Q4 (65.2% to 60.2%). On balance, the company is executing well in a favourable input-cost environment and maintains an exceptionally clean balance sheet.

Alivus Life Q1 FY27 key financials
MetricValueYoYQoQ
Revenue₹640.41 Cr6.41%-7.07%
EBIT₹212.22 Cr30.21%
Net profit₹160.08 Cr31.71%
EPS₹13.0431.58%
EBIT margin28.3%

P&L walk

Revenue growth of 6.4% YoY was driven by volume/mix as gross margin expanded 521bps on lower cost of materials consumed (39.5% vs 44.7% of revenue). EBITDA margin jumped 249bps YoY to 28.3% on the gross margin tailwind plus operating leverage from employee costs growing only 10.8% vs revenue 6.4% (fixed/semi-fixed overheads controlled). Net profit grew substantially faster (+31.7% YoY) boosted by other income tripling to ₹224.01 Mn (treasury yields on cash). EPS tracking PAT with negligible dilution.

Segments

Single API segment — no internal segmentation; all revenue and profit reflect the API business.

Key positives

Key concerns

View original filing

Research and educational content only. Not investment advice.